SEC Form 4 · accession 0001225208-17-010502
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine M. Szyman
Officer — CVP, Critical Care & Vascular
Period of report
Feb 22, 2017
Accepted (ET)
May 26, 2017 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2017 | F | 527 | $89.74 | D | 46,001 | D | |
| Common StockF1 | Feb 22, 2017 | F | 2,364 | $89.74 | D | 43,637 | D | |
| Common Stock | holding | — | — | — | 3,942 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.